TrialJournal of the American Heart Association2020

Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.

Remo H M Furtado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.